Navigation Links
Merz, Inc. Announces Promotion of Katrina Church to Vice President, Chief Compliance Officer
Date:7/9/2012

GREENSBORO, N.C., July 9, 2012 /PRNewswire/ -- Merz, Inc. (US affiliate of Merz Pharma Group) today announced that Katrina Church has been promoted to vice president, chief compliance officer, effective July 1, 2012. Church will be responsible for providing strategic and operational leadership relating to compliance issues.

"Katrina brings extensive experience and a wealth of legal knowledge in pharmaceutical regulatory compliance to her new role," said Bill Humphries, president and chief executive officer of Merz, Inc. "Merz, Inc. is committed to a tight set of core values that foster a positive, productive and unified work environment. As a company, we do what is right even when it is not easy. Katrina plays a vital role in ensuring that we uphold the highest standards and values in this dynamic regulatory environment. We look forward to working with her on the many compliance requirements facing pharmaceutical companies today."

Church joined Merz in November 2009 and has more than 20 years of legal experience in various areas, including private legal practice and in-house corporate counsel positions. Prior to joining Merz, she was employed by Connetics, Inc. where she served as general counsel. Following the acquisition of Connetics by Stiefel Laboratories, Inc., in 2006, she provided legal consulting services to Stiefel.

Church graduated Magna Cum Laude from Duke University and obtained her Juris Doctor from the New York University School of Law. She is admitted to the Bar in California, certified in Healthcare Compliance and is a member of the American Corporate Counsel Association, American Health Lawyers Association, Health Care Compliance Association, and the Society of Corporate Compliance and Ethics. Church will remain at Merz, Inc. headquarters in Greensboro, N.C.

About Merz, Inc. Merz, Inc. develops and commercializes products for Merz Pharma Group. Areas of therapeutic focus include Neurology, Physiatry, Dermatology, Aesthetics, and Podiatry.

About Merz Pharma Group  Globally, the companies of Merz Pharma Group are focused on medications for treating neurological and psychiatric illnesses and thereby assume a leading role in the field of Alzheimer research.  Another important area of competency of Merz is Clinical Dermatology and Aesthetic Medicine. Merz is also active in the Health sector outside of the pharmacy. In the field of consumer products, with its established brands of tetesept® and Merz Spezial®, Merz Consumer Care is a leading provider of products for self-medication, nutritional supplements and skin care in the German-speaking area. Merz Pharma Group is a privately owned company, founded in 1908 in Frankfurt, Germany.


'/>"/>
SOURCE Merz, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Akorn, Inc. Announces Second Quarter 2012 Earnings Release And Conference Call Information
2. ShangPharma Announces Receipt of "Going Private" Proposal at $8.50 to $9.50 Per ADS
3. Aoxing Pharmaceutical Company Announces Management Change
4. Oncos Therapeutics Announces Clinical Advisory Board for its Oncolytic Virus and Cancer Immunotherapy Development Programs
5. Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.
6. ULURU Inc. Announces Completion Of $2.2mil Convertible Debt Offering
7. Omeros Announces Closing of $34.5 Million Public Offering of Common Stock
8. Amylin Pharmaceuticals, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Bristol-Myers Squibb Company
9. MicroVention Announces First Patient Enrollment In Clinical Trial To Compare Coiling Technologies For Treating Brain Aneurysms
10. Omron Healthcare Announces New Pedometers
11. Improved Maintenance and Control of Electronic Health Records. ICAP Patent Brokerage Announces for Auction Patented Techniques for Improved Patient Control and Selective Access to Electronic Medical Records
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2017)... PROVIDENCE, R.I. , Sept. 18, 2017 ... in the fields of bioinformatics and immune ... to develop a protective avian influenza A (H7N9) vaccine. ... is distantly related to seasonal influenza and ... approaches, which rely on prior exposure to be ...
(Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform ... published the first annual edition of its Global CSR Risk and Performance ... evaluated by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data ... ... ...
(Date:9/12/2017)... FRANCISCO , Sept. 12, 2017  ValGenesis ... Management Solutions (VLMS), is pleased to announce the ... a member of its Board of Directors and ... ValGenesis VLMS enables life science companies to manage ... the use of paper in this process. Furthermore, ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... , ... PurhealthRX , a leading Health and Nutrition Company, is announcing ... full spectrum CBD oil will revolutionize the rapidly growing CBD market by reducing the ... incorporated into liquid products, while reducing costs to end users. , The team of ...
(Date:10/13/2017)... N.J. (PRWEB) , ... October 13, 2017 , ... The ... Holly Day Market. Featuring a collection of specialty vendors and unique items from across ... personalized and quality-focused health and wellness services offered by the VNA. The boutique ...
(Date:10/13/2017)... Fairfax, VA (PRWEB) , ... October 13, 2017 ... ... provider of DevOps and Agile Software Development, has been awarded a contract by ... (EATS) Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... Planet Fitness, ... the U.S., announced today its plans to open a flagship location in Covington, LA ... the former Rooms To Go store next to Office Depot in the Holiday Square ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about ... intend to develop to enable prevention of a major side effect of chemotherapy ... especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as ...
Breaking Medicine News(10 mins):